Related Experiment Video
Updated: Dec 13, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Impact of Hypertension on Cognitive Decline and Dementia
1Department of Neurology, Brunei Neuroscience Stroke & Rehabilitation Centre, Jerudong, Brunei Darussalam.
Insights
Treating hypertension in middle-aged and older adults may reduce dementia incidence. The Systolic Hypertension in Europe trial showed calcium-channel blockers significantly lowered dementia risk.
Area of Science:
- Neurology
- Gerontology
- Cardiology
Background:
- Dementia significantly impairs daily living and is a leading global cause of morbidity.
- Preventive measures for dementia are largely ineffective.
- Hypertension is linked to vascular dementia and may influence Alzheimer disease pathology.
Purpose of the Study:
- To review randomized controlled trials on antihypertensive treatments and their impact on cognitive decline.
- To assess the potential of hypertension management in reducing dementia incidence.
Main Methods:
- Review of randomized controlled studies investigating antihypertensive effects on cognition.
- Analysis of observational data linking hypertension to brain changes and cognitive decline.
- Examination of cohort studies on hypertension treatment duration and cognitive decline.
Main Results:
- Observational studies indicate hypertension is associated with white matter lesions, hippocampal atrophy, and cognitive decline.
- Both elevated and reduced blood pressure levels correlate with white matter lesion development.
- The Systolic Hypertension in Europe (Syst-EUR) trial, using calcium-channel blockers, was the only study to show a significant decrease in dementia incidence.
Conclusions:
- Active hypertension treatment in middle-aged and older adults may be a viable strategy to reduce dementia incidence.
- Current evidence from randomized trials is limited, with only one trial demonstrating a significant benefit.
- Further research is necessary to confirm the long-term efficacy of antihypertensive therapies in preventing dementia.
Abstract:
Dementia reduces a person's ability to perform their activities of daily living and is the leading cause of morbidity worldwide. While most preventive measures are ineffective in reducing dementia risk, active treatment of hypertension in middle-aged and older adults without dementia may reduce the incidence of dementia. Hypertension is associated with vascular dementia but may also affect the manifestations of Alzheimer disease. Observational studies support the association between hypertension and white matter lesions, hippocampal atrophy, and cognitive decline. Both increased and decreased blood pressure were related to the development of white matter lesions. Cohort studies showed that hypertension treatment and treatment duration were associated with lower cognitive decline. This review describes findings from randomized controlled studies on the effects of antihypertensives on cognitive decline. Only the Systolic Hypertension in Europe (Syst-Eur) trial using calcium-channel blockers demonstrated a significant reduction in dementia incidence. Further studies are required to evaluate the long-term benefits of antihypertensive treatment in dementia.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Dementia
The progression of dementia is generally gradual....
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Hypertension V: Nursing Management
Cognitive Development During Adulthood

